Altimmune, Inc. (ALT)
1 Item 5.02 filing since 2026-10-27 · roles: Director. Nasdaq. Pharmaceutical Preparations. State: MD.
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 30 | 2026-10-27 | Retirement announced | Director | subscribers | — | Altimmune, Inc. (ALT): director John Gill to retire |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works